Vistin Pharma Sells Opioids/CMO business to TPI Enterprises

25.07.2017 - Norway’s Vistin Pharma has agreed to sell its opioids and tablet manufacturing business (CMO) to Australia’s TPI Enterprises for 100 million Norwegian krone ($12.5 million). On the...